Neurology · 2003 · 122 citations · 10 references
Life SciencesImmunologyNeurologyAutoimmunityImmunotherapyNeuromuscular DisordersAutoantibodiesAutoimmune Disease DiagnosticsAutoimmune DiseasesMyasthenia GravisNeuromuscular JunctionNeuromuscular Junction DisordersAnti-muscle-specific Kinase AntibodiesConfirmatory Diagnostic TestingMuscle-specific Kinase AntibodiesMyasthenia Gravis TestingNeuromuscular Junction AntibodiesNeuromuscular Junction TransmissionRespiratory Muscle InvolvementRespiratory Musculature
This 10-year (1991 to 2000) prospective study of MG in the county of Osona (Barcelona, Spain) reveals an annual incidence rate of 21.27 cases per million inhabitants (95% CI 13.89 to 31.16). Incidence increased from 5.03 x 10(6) in the age group of 0 to 14 years to 14.68 x 10(6) in the age group of 15 to 64 years and to 63.38 x 10(6) in the older population. These results, the highest reported to date, may be explained by the population aging.
10
Incidence and prevalence of myasthenia gravis in western Denmark
Peter Christensen, Troels S. Jensen, Ioannis Tsiropoulos et al. · Neurology · 1993 · 72 citations